Perivascular Spaces as Determinants of Amyloid, Tau, and Vascular Biomarker Progression - Summary - MDSpire

The Role of Perivascular Spaces in the Progression of Amyloid, Tau, and Vascular Biomarkers

  • By

  • Audrey Low

  • Jeffrey L. Gunter

  • Mingzhao Hu

  • Sheelakumari Raghavan

  • Scott A. Przybelski

  • Christopher G. Schwarz

  • Kejal Kantarci

  • Val J. Lowe

  • Ronald C. Petersen

  • Jonathan Graff-Radford

  • Clifford R. Jack

  • Prashanthi Vemuri

  • July 17, 2026

Share

Objective:

To investigate associations between perivascular spaces (PVS) burden and future biomarker trajectories of amyloid, tau, and white matter hyperintensity (WMH) processes in Alzheimer's disease.

Approach:
  • Participants: Participants were drawn from the Mayo Clinic Study of Aging (MCSA) and the Mayo Alzheimer's Disease Research Center (ADRC), including individuals aged 30-100 with varying cognitive statuses.
  • Image Acquisition: Images were acquired on 3T Siemens Prisma scanners using standardized protocols for structural MRI across both cohorts.
  • Image Processing: A 3-step image processing approach was employed, including affine registration, segmentation using SPM12, and optimization with expanded contrast models.
Key Findings:
  • PVS burden is linked to an elevated risk of developing dementia, independent of vascular risk factors.
  • PVS can be detected on MRI earlier than other markers of small vessel disease.
  • Cerebrovascular dysfunction may accelerate the accumulation of amyloid plaques and tau tangles.
Interpretation:

Limitations:
  • PVS remains an understudied phenomenon in humans.
  • Prior studies relied on subjective visual ratings of PVS burden.
Conclusion:

Original Source(s)

Related Content